Document Server@UHasselt >
Research >
Research publications >

Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/21570

Title: Resource utilisation and direct costs in patients with recently diagnosed fibromyalgia who are offered one of three different interventions in a randomised pragmatic trial
Authors: van Eijk-Hustings, Yvonne
Kroese, Marielle
Creemers, An
Landewe, Robert
Boonen, Annelies
Issue Date: 2016
Citation: CLINICAL RHEUMATOLOGY, 35 (5), p. 1307-1315
Abstract: The purpose of this study is to understand the course of costs over a 2-year period in a cohort of recently diagnosed fibromyalgia (FM) patients receiving different treatment strategies. Following the diagnosis, patients were randomly assigned to a multidisciplinary programme (MD), aerobic exercise (AE) or usual care (UC) without being aware of alternative interventions. Time between diagnosis and start of treatment varied between patients. Resource utilisation, health care costs and costs for patients and families were collected through cost diaries. Mixed linear model analyses (MLM) examined the course of costs over time. Linear regression was used to explore predictors of health care costs in the post-intervention period. Two hundred three participants, 90 % women, mean (SD) age 41.7 (9.8) years, were included in the cohort. Intervention costs per patient varied from (sic)864 to 1392 for MD and were (sic)121 for AE. Health care costs (excluding intervention costs) decreased after diagnosis, but before the intervention in each group, and increased again afterwards to the level close to the diagnostic phase. In contrast, patient and family costs slightly increased over time in all groups without initial decrease immediately after diagnosis. Annualised health care costs post-intervention varied between (sic)1872 and 2310 per patient and were predicted by worse functioning and high health care costs at diagnosis. In patients with FM, health care costs decreased following the diagnosis by a rheumatologist. Offering patients a specific intervention after diagnosis incurred substantial costs while having only marginal effects on costs.
Notes: [van Eijk-Hustings, Yvonne] Maastricht Univ, Med Ctr, Dept Patient & Care, POB 5800, NL-6202 AZ Maastricht, Netherlands. [van Eijk-Hustings, Yvonne; Kroese, Marielle; Boonen, Annelies] Maastricht Univ, Sch Publ Hlth & Primary Care, CAPHRI, NL-6202 AZ Maastricht, Netherlands. [Creemers, An] Hasselt Univ, Dept Biostat, Hasselt, Belgium. [Landewe, Robert] Univ Amsterdam, Acad Med Ctr, Atrium Med Ctr Heerlen, Dept Internal Med,Div Rheumatol, Heerlen, Netherlands. [Boonen, Annelies] Maastricht Univ, Med Ctr, Dept Internal Med, Div Rheumatol, NL-6202 AZ Maastricht, Netherlands.
URI: http://hdl.handle.net/1942/21570
DOI: 10.1007/s10067-015-3067-y
ISI #: 000374970300022
ISSN: 0770-3198
Category: A1
Type: Journal Contribution
Validation: ecoom, 2017
Appears in Collections: Research publications

Files in This Item:

Description SizeFormat
published version420.24 kBAdobe PDF

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.